CS
CMD

Cannell & Spears’s Cantel Medical Corporation CMD Stock Holding History

Cannell & Spears’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,642
Closed -$211K – 251
2021
Q1 		$211K Sell
2,642
-4,466
-63% -$349K 0.02% 217
2020
Q4 		$561K Sell
7,108
-56,580
-89% -$3.32M 0.05% 123
2020
Q3 		$2.8M Buy
63,688
+1,502
+2% +$74K 0.27% 52
2020
Q2 		$2.75M Buy
62,186
+56,284
+954% +$2.1M 0.29% 52
2020
Q1 		$212K Buy
+5,902
New +$336K 0.03% 188

Cannell & Spears's CMD Position: Q2 2021 in Review

Cannell & Spears sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 2,642 shares — an estimated $211K sold.

Cannell & Spears first reported a position in CMD in Q1 2020 and held it in 5 quarters. The position peaked at $2.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Cannell & Spears reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Cannell & Spears sold 2,642 Cantel Medical Corporation shares in Q2 2021, an estimated $211K.
  • Cannell & Spears first reported a position in Cantel Medical Corporation in Q1 2020 and held it in 5 quarters.
  • Cannell & Spears's Cantel Medical Corporation position peaked at $2.8M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Cannell & Spears's 13F filing for Q2 2021, filed 9 Aug 2021.